Literature DB >> 9692991

Analysis of a series of phenylalanine 57 mutants of the adipocyte lipid-binding protein.

M A Simpson1, D A Bernlohr.   

Abstract

The importance of phenylalanine 57, an adipocyte lipid-binding protein (ALBP) portal residue, to ligand affinity and specificity has been investigated using a series of ALBP position 57 mutants. In wild-type ALBP, phenylalanine 57 undergoes a side chain rotation upon ligand binding, moving from an inwardly oriented, ligand-exclusive position in apoprotein structures to an outwardly oriented position in the holoprotein. To examine the role of F57 side chain rotation in the apoprotein-holoprotein transition and in ligand selectivity, ALBP site-specific mutants F57A, F57G, F57H, and F57W were expressed in Escherichia coli and purified to homogeneity. Mutants were analyzed for binding characteristics and stability toward chemical denaturation, and energy-minimized models of each mutant were constructed using apo, oleate-, and arachidonate-bound ALBP crystallographic coordinates. The stability of ALBP forms (wtALBP approximately F57G > F57A > F57W > F57H) was unrelated to the affinity of ALBP forms (wtALBP approximately F57W > F57H > F57G > F57A) for various lipids and did not vary between fatty acids. Since ligand selectivity was maintained between wild type and all mutants while ligand affinity was grossly diminished, we conclude that phenylalanine 57 is critical to the formation of the fatty acid/ALBP complex, but is uninvolved in determination of selectivity over the range of physiological ligands tested.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9692991     DOI: 10.1021/bi980507a

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  X-ray crystallographic analysis of adipocyte fatty acid binding protein (aP2) modified with 4-hydroxy-2-nonenal.

Authors:  Kristina Hellberg; Paul A Grimsrud; Andrew C Kruse; Leonard J Banaszak; Douglas H Ohlendorf; David A Bernlohr
Journal:  Protein Sci       Date:  2010-08       Impact factor: 6.725

2.  Cryo-EM, X-ray diffraction, and atomistic simulations reveal determinants for the formation of a supramolecular myelin-like proteolipid lattice.

Authors:  Salla Ruskamo; Oda C Krokengen; Julia Kowal; Tuomo Nieminen; Mari Lehtimäki; Arne Raasakka; Venkata P Dandey; Ilpo Vattulainen; Henning Stahlberg; Petri Kursula
Journal:  J Biol Chem       Date:  2020-04-07       Impact factor: 5.157

3.  Spin-system heterogeneities indicate a selected-fit mechanism in fatty acid binding to heart-type fatty acid-binding protein (H-FABP).

Authors:  C Lücke; M Rademacher; A W Zimmerman; H T van Moerkerk; J H Veerkamp; H Rüterjans
Journal:  Biochem J       Date:  2001-03-01       Impact factor: 3.857

4.  A novel polymorphism in the chicken adipocyte fatty acid-binding protein gene (FABP4) that alters ligand-binding and correlates with fatness.

Authors:  Qigui Wang; Tianzhu Guan; Hui Li; David A Bernlohr
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  2009-07-10       Impact factor: 2.231

5.  Identification and characterization of a small molecule inhibitor of Fatty Acid binding proteins.

Authors:  Ann V Hertzel; Kristina Hellberg; Joseph M Reynolds; Andrew C Kruse; Brittany E Juhlmann; Anne J Smith; Mark A Sanders; Douglas H Ohlendorf; Jill Suttles; David A Bernlohr
Journal:  J Med Chem       Date:  2009-10-08       Impact factor: 7.446

6.  Concerted dynamic motions of an FABP4 model and its ligands revealed by microsecond molecular dynamics simulations.

Authors:  Yan Li; Xiang Li; Zigang Dong
Journal:  Biochemistry       Date:  2014-10-02       Impact factor: 3.162

7.  Structure and dynamics of a human myelin protein P2 portal region mutant indicate opening of the β barrel in fatty acid binding proteins.

Authors:  Saara Laulumaa; Tuomo Nieminen; Arne Raasakka; Oda C Krokengen; Anushik Safaryan; Erik I Hallin; Guillaume Brysbaert; Marc F Lensink; Salla Ruskamo; Ilpo Vattulainen; Petri Kursula
Journal:  BMC Struct Biol       Date:  2018-06-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.